Buys | $583,390 | 3 | 43 |
Sells | $22,516 | 4 | 57 |
MATLIN DAVID J | director | 1 | $438,458 | 0 | $0 | $438,458 |
Mortenson Mark | Chief Science Officer | 1 | $97,432 | 0 | $0 | $97,432 |
Etherington Robert Dee | Chief Executive Officer | 1 | $47,500 | 0 | $0 | $47,500 |
General Resonance LLC | 10 percent owner | 0 | $0 | 4 | $22,516 | $-22,516 |
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy …
Over the last 12 months, insiders at Clene Inc. have bought $583,390 and sold $22,516 worth of Clene Inc. stock.
On average, over the past 5 years, insiders at Clene Inc. have bought $6.12M and sold $530,982 worth of stock each year.
Highest buying activity among insiders over the last 12 months: MATLIN DAVID J (director) — $438,458. Mortenson Mark (Chief Science Officer) — $97,432. Etherington Robert Dee (Chief Executive Officer) — $47,500.
The last purchase of 92,307 shares for transaction amount of $438,458 was made by MATLIN DAVID J (director) on 2024‑09‑30.
2024-09-30 | MATLIN DAVID J | director | 92,307 1.4829% | $4.75 | $438,458 | +3.92% | ||
2024-09-30 | Etherington Robert Dee | Chief Executive Officer | 10,000 0.1606% | $4.75 | $47,500 | +3.92% | ||
2024-09-30 | Mortenson Mark | Chief Science Officer | 20,512 0.3295% | $4.75 | $97,432 | +3.92% | ||
2024-05-01 | Sale | General Resonance LLC | 10 percent owner | 13,000 0.0092% | $0.40 | $5,148 | -41.88% | |
2024-04-30 | Sale | General Resonance LLC | 10 percent owner | 13,000 0.0098% | $0.42 | $5,416 | -41.20% | |
2024-04-24 | Sale | General Resonance LLC | 10 percent owner | 10,000 0.0076% | $0.33 | $3,278 | -23.89% | |
2024-04-09 | Sale | General Resonance LLC | 10 percent owner | 22,500 0.0172% | $0.39 | $8,675 | -33.35% | |
2023-11-10 | MATLIN DAVID J | director | 250,002 0.1815% | $0.41 | $102,501 | -21.11% | ||
2023-06-26 | Stevens John Henry | director | 316,455 0.4161% | $0.80 | $253,164 | -45.16% | ||
2023-06-26 | Etherington Robert Dee | Chief Executive Officer | 25,000 0.0333% | $0.81 | $20,250 | -45.16% | ||
2023-06-16 | Ugwumba Chidozie | 10 percent owner | 7.5M 9.259% | $0.80 | $6M | -47.83% | ||
2023-06-16 | MATLIN DAVID J | director | 1.5M 1.8518% | $0.80 | $1.2M | -47.83% | ||
2023-06-16 | Mosca Alison | director | 2.39M 2.9559% | $0.80 | $1.92M | -47.83% | ||
2023-06-16 | Gay Jonathon | director | 105,625 0.1304% | $0.80 | $84,500 | -47.83% | ||
2022-11-02 | Ugwumba Chidozie | director | 990,099 1.4746% | $1.01 | $1,000,000 | -7.69% | ||
2022-11-02 | MATLIN DAVID J | director | 2.87M 4.2765% | $1.01 | $2.9M | -7.69% | ||
2022-11-02 | Gay Jonathon | director | 990,099 1.4746% | $1.01 | $1,000,000 | -7.69% | ||
2022-11-02 | Mosca Alison | director | 792,079 1.1797% | $1.01 | $800,000 | -7.69% | ||
2022-11-02 | Stevens John Henry | director | 148,515 0.2212% | $1.01 | $150,000 | -7.69% | ||
2022-08-17 | Stevens John Henry | 47,662 0.0756% | $3.85 | $183,499 | -72.25% |
MATLIN DAVID J | director | 444491 5.3387% | $2.03M | 22 | 0 | <0.0001% |
Etherington Robert Dee | Chief Executive Officer | 40149 0.4822% | $183,079.44 | 2 | 1 | <0.0001% |
Mortenson Mark | Chief Science Officer | 28949 0.3477% | $132,007.44 | 1 | 1 | |
Ugwumba Chidozie | 10 percent owner | 13018908 156.3675% | $59.37M | 2 | 0 | <0.0001% |
Mosca Alison | director | 3238375 38.8955% | $14.77M | 4 | 0 | <0.0001% |
$22,186,116 | 57 | -43.73% | $37.31M | |
$140,938,207 | 36 | 14.75% | $41.76M | |
Clene Inc. (CLNN) | $23,895,365 | 34 | -37.28% | $37.97M |
$241,165 | 22 | -16.72% | $40.55M | |
$167,476,357 | 20 | -1.54% | $41.64M |
Increased Positions | 13 | +50% | 161,968 | +15.95% |
Decreased Positions | 9 | -34.62% | 688,390 | -67.78% |
New Positions | 9 | New | 114,175 | New |
Sold Out Positions | 3 | Sold Out | 684,257 | Sold Out |
Total Postitions | 30 | +15.38% | 489,213 | -51.83% |
Vanguard Group Inc | $574.00 | 1.62% | 129,620 | -1,486 | -1.13% | 2024-12-31 |
Scoggin Management Lp | $443.00 | 1.25% | 100,000 | +25,000 | +33.33% | 2024-12-31 |
Geode Capital Management, Llc | $288.00 | 0.81% | 65,112 | +22,539 | +52.94% | 2024-12-31 |
Parsons Capital Management Inc/Ri | $162.00 | 0.46% | 36,500 | +36,500 | New | 2024-12-31 |
Lunt Capital Management, Inc. | $132.00 | 0.37% | 29,793 | +253 | +0.86% | 2024-12-31 |
Citadel Advisors Llc | $92.00 | 0.26% | 20,835 | +20,835 | New | 2024-12-31 |
Renaissance Technologies Llc | $80.00 | 0.23% | 18,040 | +18,040 | New | 2024-12-31 |
Morgan Stanley | $75.00 | 0.21% | 16,931 | 0 | 0% | 2024-12-31 |
Sbi Securities Co., Ltd. | $58.00 | 0.16% | 13,025 | +13,025 | New | 2024-12-31 |
Fullcircle Wealth Llc | $58.00 | 0.16% | 13,023 | +13,023 | New | 2024-12-31 |